Related references
Note: Only part of the references are listed.Pharmacogenetic profiling of CD133 is associated with response rate (RR) and progression-free survival (PFS) in patients with metastatic colorectal cancer (mCRC), treated with bevacizumab-based chemotherapy
A. Pohl et al.
PHARMACOGENOMICS JOURNAL (2013)
Relationship of increased aurora kinase A gene copy number, prognosis and response to chemotherapy in patients with metastatic colorectal cancer
E. Dotan et al.
BRITISH JOURNAL OF CANCER (2012)
Aurora-A activation, correlated with hypoxia-inducible factor-1α, promotes radiochemoresistance and predicts poor outcome for nasopharyngeal carcinoma
Xiang-Bo Wan et al.
CANCER SCIENCE (2012)
Aurora B confers cancer cell resistance to TRAIL-induced apoptosis via phosphorylation of survivin
Mi Jin Yoon et al.
CARCINOGENESIS (2012)
Search for Novel Target Molecules for the Effective Treatment or Prevention of Colorectal Cancer
Masahiko Tsujii
DIGESTION (2012)
Marked upregulation of Survivin and Aurora-B kinase is associated with disease progression in the myelodysplastic syndromes
Akira Yoshida et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
The Aurora A and B kinases are up-regulated in bone marrow-derived chronic lymphocytic leukemia cells and represent potential therapeutic targets
Francisco de Paula Careta et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Inhibiting the Aurora B Kinase Potently Suppresses Repopulation During Fractionated Irradiation of Human Lung Cancer Cell Lines
Ali Sak et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Selective FLT3 inhibition of FLT3-ITD+ acute myeloid leukaemia resulting in secondary D835Y mutation: a model for emerging clinical resistance patterns
A. S. Moore et al.
LEUKEMIA (2012)
High expression of nuclear survivin and Aurora B predicts poor overall survival in patients with head and neck squamous cell cancer
O. P. Erpolat et al.
STRAHLENTHERAPIE UND ONKOLOGIE (2012)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
The Aurora Kinase Inhibitor CCT137690 Downregulates MYCN and Sensitizes MYCN-Amplified Neuroblastoma In Vivo
Amir Faisal et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Copy number increase of aurora kinase A in colorectal cancers: a correlation with tumor progression
Chao Zhang et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2010)
Aurora-A Is Essential for the Tumorigenic Capacity and Chemoresistance of Colorectal Cancer Stem Cells
Patrizia Cammareri et al.
CANCER RESEARCH (2010)
Imidazo[4,5-b]pyridine Derivatives As Inhibitors of Aurora Kinases: Lead Optimization Studies toward the Identification of an Orally Bioavailable Preclinical Development Candidates
Vassilios Bavetsias et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Epidemiology of colorectal cancer in Asia
Yuk Kei Yee et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2009)
Aurora kinase expression in colorectal adenocarcinoma: correlations with clinicopathological features, p16 expression, and telomerase activity
Alfred King-Yin Lam et al.
HUMAN PATHOLOGY (2008)
PHA-739358, a potent inhibitor of Aurora kinases with a selective target inhibition profile relevant to cancer
Patrizia Carpinelli et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Aurora-a, a negative prognostic marker, increases migration and decreases radiosensitivity in cancer cells
Zhong Guan et al.
CANCER RESEARCH (2007)
Inhibition of survivin and aurora B kinase sensitizes mesothelioma cells by enhancing mitotic arrests
Kwang Woon Kim et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
High copy amplification of the Aurora-A gene is associated with chromosomal instability phenotype in human colorectal cancers
Naoshi Nishida et al.
CANCER BIOLOGY & THERAPY (2007)
Phase II study of capecitabine (Xeloda®) and concomitant boost radiotherapy in patients with locally advanced rectal cancer
Sunil Krishnan et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world
Farin Kamangar et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Increasing incidence of colorectal cancer in Asia: implications for screening
JJY Sung et al.
LANCET ONCOLOGY (2005)
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
EA Harrington et al.
NATURE MEDICINE (2004)
Aurora-a kinase maintains the fidelity of early and late mitotic events in HeLa cells
T Marumoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Drosophila aurora-A is required for centrosome maturation and actin-dependent asymmetric protein localization during mitosis
D Berdnik et al.
CURRENT BIOLOGY (2002)
Share Paper
